Placeholder Banner

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

February 25, 2014
In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John J. Castellani, president of PhRMA, write that context must accompany the data being provided under the Physician Payments Sunshine Act:

"Discovery of new and improved medicines would be impossible without collaborations between physicians and biopharmaceutical companies. Consider ongoing research and clinical trials that not only make medicines possible, but also help our understanding of disease. Biopharmaceutical professionals help physicians stay current on the latest treatments and, in turn, physicians share patient experiences with their medicines..."

Read the full letter on USA Today